Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine

Viral Immunology

Volumn 9, Issue 4, 1996, Pages 241-245

  Hayward, Anthony R ^a   Buda, Kim ^a   Jones, Michelle ^a   White, C Jo ^b   Levin, Myron J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; INACTIVATED VACCINE; LIVE VACCINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; EPSTEIN BARR VIRUS; FIBROBLAST; HEATING; HUMAN; HUMAN CELL; IMMUNIZATION; LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; TARGET CELL; VARICELLA ZOSTER VIRUS; VIRUS ATTENUATION;

EID: 0030464917     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1996.9.241     Document Type: Article

References (15)

1. Ada, G.L., K.N. Leung, and H. Ertl. 1981. An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses. Immunol. Rev. 58:5-24.
2. Arvin, A.M., M. Sharp, S. Smith, C.M. Koropchak, P.S. Diaz, P. Kinchington, W. Ruyechan, and J. Hay. 1991. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J. Immunol. 146:257-264.
3. Debrick, I.E., P.A. Campbell, and U.D. Staerz. 1991. Macrophages as accessory cells for class I MHC-restricted immune responses. J. Immunol. 147:2846-2851.
4. Dillon, S.B., S.G. Demuth, M.A. Schneider, C.B. Weston, C.S. Jones, J.F. Young, M. Scott, P.K. Bhatnaghar, S. LoCastro, and N. Hanna. 1992. Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine 10:309-318.
5. Germain, R.N., D.H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Ann. Rev. Immunol. 11:403-405.
6. Hayward, A.R., K. Buda, and M.J. Levin. 1994. Immune Response to Secondary Immunization with Live or Inactivated VZV Vaccine in Elderly Adults. Viral Immunol. 7:31-36.
7. Hayward, A.R., R. Burger, R. Scheper, and A.M. Arvin. 1991. MHC Restriction of T cell responses to varicella zoster virus in guinea pigs. J. Virol. 65:1491-1495.
8. Hayward, A.R., O. Pontesilli, M. Herberger, M. Lazslo, and M. Levin. 1986. Specific lysis of VZV infected B lymphoblasts by human T cells. J. Virol. 58:179.
9. Hayward, A.R., M. Herberger, and M. Laszlo. 1986. Cellular interactions in the lysis of varicella zoster virus infected human fibroblasts. Clin. Exp. Immunol. 63:141-148.
10. Huang, Z., A. Vafai, J. Lee, R. Mahalingam, and A.R. Hayward. 1992. Specific lysis of targets expressing varicella zoster virus GpI or GpIV by CD4+ human T cell clones. J. Virol. 66:2664-2669.
11. Kamiya, H., S.E. Starr, A.M. Arbeter, and S.A. Plotkin. 1982. Antibody-dependent cell-mediated cytotoxicity against varicella-zoster virus-infected targets. Infect. Immun. 38:554-557.
12. Plotkin, S.A. 1994. Vaccines for varicella-zoster virus and cytomegalovirus: recent progress. Science 265:1383-1385.
13. Pontesilli, O., P. Carotenuto, M.J. Levin, D.J. Suez, and A.R. Hayward. 1987. Processing and presentation of cell-associated varicella zoster antigens by human monocytes. Clin. Exp. Immunol. 70:127-135.
14. Ragozzino, M.W., L.J. Melton, L.T. Kurland, C.P. Chu, and H.O. Perry. 1982. Population-based study of herpes zoster and its sequelae. Medicine 61:310-316.
15. Sperber, S.J., B.V. Smith, F.G. Hayden. 1992. Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine. Antiviral Res. 17:213-222.